The Challenge
Shire retained PharmaBioSource Realty as its exclusive real estate broker to divest its 93,000-square-foot mammalian cell culture roller bottle drug substance manufacturing site near Boston, Massachusetts.
The Solution
PharmaBioSource Realty marketed the site to strategic acquirers.
Services provided by the PharmaBioSource Realty team:
- Benchmark valuation
- Buyer target identification and engagement
- Creation of the Confidential Information Memorandum (CIM)
- Data room development
- Due diligence support
- Negotiations and closing support
The Results
PharmaBioSource Realty identified Rentschler Biopharma, a Germany-based biotech CDMO, as the acquirer. Rentschler acquired the site to establish its first laboratory and manufacturing presence in the U.S. The site acquisition also included a supply agreement to manufacture products for Shire.
What We Did
Real Estate Brokerage
Facility Divestiture